Famprofazone

CAS No. 22881-35-2

Famprofazone( Famprofazone | Geodowin | BRN 5768367 | BRN-5768367 | BRN5768367 )

Catalog No. M13633 CAS No. 22881-35-2

Famprofazone (Gewodin, Gewolen) is a non-steroidal anti-inflammatory agent (NSAID) of the pyrazolone series .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 49 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Famprofazone
  • Note
    Research use only, not for human use.
  • Brief Description
    Famprofazone (Gewodin, Gewolen) is a non-steroidal anti-inflammatory agent (NSAID) of the pyrazolone series .
  • Description
    Famprofazone (Gewodin, Gewolen) is a non-steroidal anti-inflammatory agent (NSAID) of the pyrazolone series . It has analgesic, anti-inflammatory, and antipyretic effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Famprofazone | Geodowin | BRN 5768367 | BRN-5768367 | BRN5768367
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX-1| COX-2
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    22881-35-2
  • Formula Weight
    377.52
  • Molecular Formula
    C24H31N3O
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in DMSO
  • SMILES
    O=C1N(C2=CC=CC=C2)N(C)C(CN(C)C(C)CC3=CC=CC=C3)=C1C(C)C
  • Chemical Name
    4-isopropyl-1-methyl-5-((methyl(1-phenylpropan-2-yl)amino)methyl)-2-phenyl-1,2-dihydro-3H-pyrazol-3-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Chan KH, et al. J Anal Toxicol. 2010 Jul-Aug;34(6):347-53.
molnova catalog
related products
  • Deracoxib

    A selective COX-2 inhibitor that is a non-narcotic, non-steroidal anti-inflammatory drug (NSAID).

  • Cimicoxib

    Cimicoxib is a potent and selective inhibitor of COX-2 with anti-inflammatory and analgesic activity.

  • Etoricoxib

    Etoricoxib(MK-0663) selectively inhibited COX-2 in human whole blood assays in vitro, with an IC50 value of 1.1 ± 0.1 μM for COX-2 (LPS-induced prostaglandin E2 synthesis), compared with an IC50 value of 116 ± 8 μM for COX-1 (serum thromboxane B2 generation after clotting of the blood).